Processing

Please wait...

Settings

Settings

1. WO1996005304 - INTEGRIN BLOCKING MOLECULES

Publication Number WO/1996/005304
Publication Date 22.02.1996
International Application No. PCT/US1995/010138
International Filing Date 08.08.1995
Chapter 2 Demand Filed 15.02.1996
IPC
A61K 38/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/47 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/4703
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
4701not used
4702Regulators; Modulating activity
4703Inhibitors; Suppressors
Applicants
  • ATHENA NEUROSCIENCES, INC. [US/US]; 800 Gateway Boulevard South San Francisco, CA 94080, US (AllExceptUS)
  • BARD, Frederique [FR/US]; US (UsOnly)
  • YEDNOCK, Theodore, A. [US/US]; US (UsOnly)
  • KEIM, Pamela, S. [US/US]; US (UsOnly)
  • BASI, Guriqbal, Singh [US/US]; US (UsOnly)
Inventors
  • BARD, Frederique; US
  • YEDNOCK, Theodore, A.; US
  • KEIM, Pamela, S.; US
  • BASI, Guriqbal, Singh; US
Agents
  • DUNN, Tracy, J. ; Townsend and Townsend and Crew One Market Plaza 20th floor Steuart Street Tower San Francisco, CA 94105, US
Priority Data
08/287,73009.08.1994US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) INTEGRIN BLOCKING MOLECULES
(FR) MOLECULES DE BLOCAGE DE L'INTEGRINE
Abstract
(EN)
The invention relates to protein or polypeptide compositions capable of inhibiting leukocyte adhesion to, and transmigration across endothelial tissue. The invention further relates to nucleic acid molecules encoding such peptides, pharmaceutical compositions containing such peptides and methods of using such polypeptides.
(FR)
L'invention concerne des compositions de protéines ou polypeptides pouvant inhiber l'adhérence des leucocytes au tissu endothélial et leur transmigration au travers de celui-ci. Elle concerne aussi des molécules d'acides nucléiques qui codent de tels peptides, des compositions pharmaceutiques contenant ces peptides et des procédés permettant d'utiliser ces polypeptides.
Also published as
Latest bibliographic data on file with the International Bureau